Darmstadt (Alemania), 6 mar — La empresa tecnológica y farmacéutica Merck aumentó su facturación un 0,8 % hasta 21.100 ...
La compañía alemana cerró el ejercicio con un crecimiento del 2% de su facturación y del 6,9% del Ebitda. Entre sus fármacos, ...
El laboratorio alemán Merck ganó 2.786 millones de euros en 2024, lo que supone un 1,7% menos que el año anterior, cuando ...
Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...
Merck KGaA said it’s in advanced talks to purchase SpringWorks Therapeutics Inc., sending shares of the US cancer and rare diseases drugmaker soaring. One of SpringWorks’ drugs, Ogsiveo, is ...
Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback